Article Text

PDF
Anti-collagen type II antibodies in patients with very early synovitis
  1. K Raza1,2,
  2. M Mullazehi3,
  3. M Salmon1,
  4. C D Buckley1,2,
  5. J Rönnelid3
  1. 1
    MRC Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, UK
  2. 2
    Department of Rheumatology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK
  3. 3
    Unit of Clinical Immunology, Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Sweden
  1. Dr K Raza, PhD MRCP, MRC Centre for Immune Regulation, Division of Immunity and Infection, The University of Birmingham, Birmingham B15 2TT, UK; k.raza{at}bham.ac.uk

Statistics from Altmetric.com

Anti-type II collagen (anti-CII) antibodies have been reported in between 3% and 27% of patients with rheumatoid arthritis (RA).1 3 In contrast with anti-cyclic citrullinated peptide (anti-CCP) antibodies,4 5 anti-CII antibodies are absent before the onset of synovitis6 and decrease over the first few years of disease.2 3 Anti-CII antibody levels thus appear to peak around the time of diagnosis of RA when they are associated with active inflammation.3 The pathological processes operating in the joints of patients with very early synovitis who develop RA are distinct from those in other patients with early synovitis and are characterised by a cytokine profile …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.